DiscoverRadio Advisory
Claim Ownership
Radio Advisory
Author: Advisory Board
Subscribed: 78,025Played: 230,812Subscribe
Share
© 2024 Advisory Board
Description
A top podcast for healthcare leaders, with over one million downloads, Radio Advisory is your weekly download on how to untangle the industry's most pressing challenges to help leaders like you make the best business decisions for your organization.
From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com
From unpacking major trends in care delivery—like site-of-care shifts and the rise of high-cost drugs—to demystifying stakeholder dynamics, to shining a spotlight on priorities that may get overlooked, we're here to help. Our hosts and seasoned researchers talk with industry experts to equip you with knowledge to confront today's unanswered questions in healthcare. New episodes drop every Tuesday. | www.advisory.com
241 Episodes
Reverse
For years, health systems have been holding their breath to see if patient volumes would finally return to pre-pandemic levels. Because—per conventional wisdom--if volumes return, then so will operating margins. Right? Not so fast.
In this episode, host Abby Burns invites Advisory Board experts Sebastian Beckmann and Elizabeth Orr to explore why with the positive volume forecast we see in our projections won’t automatically translate to a healthy financial outlook. Later, Optum Advisory expert Alex Kist joins the group to share what it’s looked like to help one health system put their local data into action to achieve the kind of differentiated growth our experts have been touting.
Links:
Market Scenario Planner
3 ways Boulder Community Health became a provider of choice for CV care
Revolutionizing cardiology at Boulder Community Health
Ep. 221: How will health system growth look different in 2025 and beyond?
Healthcare Consulting Services | Optum Advisory
Advisory Board's 7 key factors for future volume growth
Charted: The financial gap between rich and poor hospitals grows
If you are looking for hands-on support, email us at podcasts@advisory.com or learn more about how Advisory Board can help.
Join 165,000+ healthcare leaders and get the industry’s most important news in your inbox—every day.
Strategic Planner's survey 2024
Survey insights: 6 priorities for health system strategists in 2024
Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
Two weeks ago on Radio Advisory, we told our listeners that the number one area of focus for health system growth is operational excellence, and a major part of that is capturing all of the revenue on the table from your medical group. Healthcare organizations have spent the last decade buying up medical groups and physicians, in part because of the “promise” of downstream referrals. It is a long-held belief that physician employment leads to higher referral integrity. But according to an Advisory Board data analysis, that doesn’t hold true - just 55% of total referral revenue attributed to employed PCPs is realized in-network.
This week, host Rachel (Rae) Woods invites Advisory Board physician experts Eliza Dailey and Colleen Wagner to unpack where referral leakage actually happens and share the real (and relatively easy) steps organizations can take to reduce referral leakage.
Links:
Tools to reduce referral leakage in the medical group
Are employed PCPs more likely to refer within their health systems?
Ep. 221: How will health system growth look different in 2025 and beyond?
Medical group integration
3 shifts impacting medical groups: 2024 update on the physician landscape
Strategic Planner's survey 2024
Survey insights: 6 priorities for health system strategists in 2024
Digital surgery: A way for orthopaedic programs to set themselves apart
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
In the midst of the COVID-19 pandemic, The Centers for Medicare & Medicaid services released the Acute Hospital Care at Home payment waiver. The action was expected to usher in a new era of home-based care. But while it’s certainly grown in recent years, frankly, that massive shift hasn’t happened. The question is, why?
This week, host Abby Burns invites Dr. Matthew Richards, Senior Medical Director of home-care enablement company Medically Home, to explore the role that home-base care could play in the future of healthcare, and to unpack the misconceptions that prevent home-based care from playing a larger role in the healthcare ecosystem today.
Links:
Home - Medically Home
5 trends (re)shaping site-of-care shifts
The future of the acute care at home model
Ep. 64: Why Contessa's CEO believes hospital at home benefits everyone (including hospitals)
Strategic Planner's survey 2024
Survey insights: 6 priorities for health system strategists in 2024
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
(This episode originally aired on September 26, 2023.)
Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misaligned expectations that leaders have around value-based care?
In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy. Throughout the conversation they discuss what leaders are currently getting wrong, how myths about value-based care are impacting the industry, and more.
Links:
Our Value-based Care playlist
Ep. 172: Build a value-based enterprise: Live from 2023 Value-Based Care Summit
Ep. 126: [Bonus content] Commercial risk is possible—here's how
How Health Plans Can Support Providers in Risk
The climb to value-based care
3 strategies for a successful sleep apnea therapy program: Lessons from ENTTX's ASC partnership
Strategic Planner's survey 2024
Survey insights: 6 priorities for health system strategists in 2024
Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.
In the last few years, all eyes have turned to GLP-1s as an industry-altering answer to obesity treatment and weight management. But the fact is, these drugs can’t – and shouldn’t – work in a vacuum. There is a fear that attention on GLP-1s may even blind leaders to the other services that go into providing effective obesity care. So, what should leaders be thinking about when designing and and delivering effective obesity care?
To answer that question, host Abby Burns invites Advisory Board experts Chloe Bakst, Payton Grimes, and Atticus Raasch to unpack what comprehensive weight management programs look like in practice, and why—if done well— they can benefit patients, clinicians, and health systems.
Links:
4 key elements of comprehensive obesity care (and how they look in practice)
How 3 health systems provide comprehensive care for obesity
Ep. 181: Does healthcare's approach to obesity harm patients?
Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs
Learn more about On-demand Courses
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
When we talk about “health systems,” it can sound like we’re talking about a monolith. But in reality, the $1.4 trillion dollar health system sector is made up of a diverse range of players. Academics and safety nets; urban and rural systems; 1,000-bed systems and 25-bed critical access hospitals. The question is, especially as systems emerge from the financial hardships of the past few years, how do those differences translate to the ways systems are running at growth?
In this episode, the third and final installment in our series leading up to Advisory Board’s Strategy Summit, host Abby Burns invites Advisory Board health system experts Elizabeth Orr and Marisa Nives to unpack how leaders across the health system sector are thinking differently about growing in 2025 and beyond.
Links:
Hospitals' top strategic priorities — and what they mean for development leaders
Ep. 220: Why AI in healthcare is more than just ChatGPT
Ep. 219: The business case for going green
Ep. 218: [Encore + bonus content] Site-of-care shifts: It's time to go on offense
Charted: The financial gap between rich and poor hospitals grows
Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024.
Learn about Advisory Board Fellowship
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
We’ve talked a lot about AI on Radio Advisory, with a particular emphasis on generative models and their capabilities. But are there other models of AI that are flying under the radar? Today’s episode focuses on computer vision and its potential to shift how we think about the use of technology in healthcare.
For the second episode in our series leading up to Advisory Board’s upcoming Strategy Summit, host Abby Burns invites digital health experts Ty Aderhold and Elysia Culver to break down why computer vision should be on our minds, arguably just as much as generative AI.
Links:
Ep. 185: AI adoption: why you can't afford to "wait and see"
10 ways computer vision can transform the future of healthcare
Computer vision in healthcare
Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024.
Register for the How to harness the potential of digital experience in healthcare webinar on September 17.
Learn more about Advisory Board Sponsorship.
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
It's no secret that climate change has had a massive effect on population health, but it’s also impacting healthcare business. Did you know that energy costs have gone up by 28% in the past five years? Health systems in particular can shave percentage points off their annual costs by reducing their energy consumption—but there is both a knowledge gap and an action gap keeping leaders from taking advantage of the opportunity.
Advisory Board’s Strategy Summit on September 10-11 is all about the pivots health systems need to make for a sustainable future – no better way to kick off our lead-up to the event than by taking that quite literally and talking about environmental sustainability.
In this episode, host Abby Burns invites Advisory Board expert Miles Cottier to break down how and why health business leaders need to prioritize environmental sustainability. They explore the financial case for moving to renewable energy sources, how regulatory pressures may (or may not) shape the future of environmental action, and what leaders can do today to support their green initiatives.
Links:
Green financing for health systems
Climate change is affecting heart health. Here’s what you can do.
Ep. 119: How health leaders can address climate change
Ep. 164: Boston Medical Center's path to sustainability (and how they're funding it)
Join us at the Pivots for a Sustainable Future Summit on September 10-11, 2024
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
This week, host Abby Burns invites Advisory Board expert Sebastian Beckmann back to Radio Advisory to provide an update—as promised—on what his team has uncovered about site-of-care shifts in the six months since he first brought this research to the pod. Hint: there’s about $50B at play.
This episode is a modified encore of Episode 195: Site-of-care shifts: It’s time to go on offense.” In that episode, Sebastian and fellow Advisory Board expert Nick Hula joined Abby to break down how health systems should be thinking about site-of-care shifts as a part of their growth strategies, including making the transition from a “defensive” mindset to prevent volume shifts, to an “offensive” mindset to capture them.
The original episode will play almost in its entirety, with interjections from Abby and Sebastian to dig deeper into what the site-of-care shift opportunity—or risk—actually looks like across markets and services.
Links:
Seize the $50 billion site-of-care shift opportunity
Interactive maps: See where site-of-care shifts are having the biggest impact
Site-of-care shifts: Healthcare’s $50B opportunity
Your guides to volume growth in 6 key service lines
4 takeaways from our updated provider volume forecast
5 trends (re)shaping site-of-care shifts
What’s happening with joint replacement volumes?
Ep. 193: Is health system growth still possible?
Learn more about On-demand Courses
Use the Market Scenario Planner
A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.
(This episode originally aired on September 12, 2023.)
With rising costs and tightening margins, the industry is continually looking for ways to "bend the cost curve" while maintaining, or even increasing, quality and performance. One stakeholder in particular, employers, are feeling significant pressures from inflation, hospital consolidation, the rise of high-cost drugs, and more. While many legacy cost-saving strategies have focused on reducing employer costs, it may be time to shift focus to lowering costs for employees as well.
In this episode, host Rachel (Rae) Woods invites Advisory Board payer expert Max Hakanson and Innovation lead at JPMorgan's Morgan Health Rivka Friedman to discuss what employers can do to rein in healthcare costs, both for themselves and their employees. Throughout the discussion, they discuss why legacy cost-sharing strategies may be insufficient, and what new innovations are showing promise in the market.
Links:
Home | Morgan Health
Ep. 165: Employer series: Is the cost of employer-sponsored insurance unsustainable?
Investigating the high costs in employer-sponsored insurance
5 health benefits strategies for self-funded employers
3 things to know about ESI (that you won't find in a benefits survey)
Learn more about Advisory Board Sponsorship
(This episode originally aired on March 12, 2024.)
The relationship between health plans and providers has always included an element of friction, but lately, it seems like the temperature is rising. And you've probably noticed – public contracting disputes increased by 69% between 2022 and 2023.
That's why, in this episode, host Abby Burns invites Advisory Board experts Max Hakanson and Eileen Fennell to discuss why the state of affairs seems to be getting worse, how key flashpoints are fanning the flames, and what each stakeholder says they need to see from their partners in order to mend the relationship. Plus, Advisory Board digital health expert Ty Aderhold makes a cameo appearance to help answer the question: Is AI the solution here?
Links:
7 things we want to fix in 2024 (and how to get there)
A new era of payer-provider relationships
The new era of provider enablement
AI in healthcare: Insights from 10 C-suite executives
Learn about the Advisory Board Fellowship
Healthcare leaders have dozens of priorities on their plates, and achieving innovation is not as simple as just buying a new technology or implementing a new care model. Frankly, it can be overwhelming not just to see innovations through, but even to get started. So, what does it really take to innovate? And how do you align your organization’s challenges with the solutions or innovations that are being presented to you?
In this special episode, live from Advisory Board’s 2024 Clinical Innovation Summit, guest host and Advisory Board digital health expert John League invites Dr. Ayo Ajaiyeoba from Blue Cross Blue Shield of Kansas City, and Elliot Green, cofounder and CEO of Dandelion Health, to dive deep on the realities of innovation. Throughout the discussion, they explore what it takes to get started, how to act in the face of ambiguity, and how you should be thinking about tools like data and partnerships to achieve your goals.
Links:
Blue Cross Blue Shield
Dandelion Health
Top 5 takeaways from our Clinical Innovation Summit
4 imperatives for the future of healthcare innovation
Truly personalized care is possible. Here's how to make it a reality.
More upcoming events from Advisory Board
Learn more about Advisory Board On-Demand Courses
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
It seems like a no-brainer for healthcare organizations to allocate time and attention to a health condition that is guaranteed to affect 50% of adults during their midlife years—but that hasn’t been the case.
We’re seeing momentum around making menopause mainstream—from the White House directing research funding, to Hollywood stars talking openly about menopause, to the rise of femtech companies geared toward helping consumers navigate the clinical and social effects of menopause. But though 100% of women in midlife will experience this clinical event, the reality is that most women’s health programs are primarily focused on what our guests have referred to in the past as the “bikini approach” to women’s health, and have largely ignored the needs of women in the post-reproductive years. From a clinical and financial standpoint, this is a missed opportunity. And given 80% of the healthcare workforce is women, and one-third of those women are in midlife, it’s also a competitive vulnerability.
That’s why this week, host Rachel (Rae) Woods invites Advisory Board women’s health experts Kara Marlatt and Gaby Marmolejos to explore how provider and employer leaders can build systems that account for and address women’s health needs “beyond the bikini.”
Links:
5 ways employers can support women's health during midlife
Five women leaders on the shifting landscape of women's health, per UnitedHealthcare (beckerspayer.com)
Ep. 188: The business case for investing in women's health
The business case for investing in women’s specialty care
Women’s health opportunity: Menopause symptom care
[Webinar, Aug. 13] Your guide to the lab and diagnostics market landscape in 2024
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
In recent years, we’ve seen large retailers like CVS, Walgreens, Walmart, and even Amazon add to their care delivery portfolios, specifically through offering low-acuity primary care services. But it seems like the tide may be shifting. In April, Walmart announced that it’s shuttering its primary care operations and virtual care arm—and it’s not the only one scaling back. The fact is, a number of retailers are retrenching on primary care operations.
In this episode, host Abby Burns invites Advisory Board experts Vidal Seegobin, Natalie Trebes, and Eliza Dailey to unpack exactly why Walmart and other retailers are pulling back on primary care delivery, and why the conventional explanation –"healthcare is too complex”– falls short.
Links:
Walmart Health is closing down. Here's what you need to know.
Another one bites the dust: What Walmart's retreat from healthcare means for providers
5 trends (re)shaping site-of-care shifts
6 insights on consumer preferences in healthcare
How Amazon, CVS, Walmart, and more are impacting provider pay
Our Disruption playlist
Ep. 130: Healthcare disruptors: Don't discount retailers
[July 25] Understand your customer: Medical groups 101
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Radio Advisory first started production in April 2020 to deliver timely, critical messages to healthcare professionals navigating the early days of the Covid-19 pandemic.
Four years, 200+ episodes, and one million downloads later, Radio Advisory continues to bring insightful conversations and valuable insights to listeners passionate about driving positive change in healthcare.
To celebrate our millionth download, host Rachel (Rae) Woods and the Radio Advisory production team revisit some of their favorite episodes over the last four years, recollect the lessons learned, and reflect on how the healthcare industry has evolved alongside us.
We owe this milestone to you, our listeners. Your support and engagement have fueled and enriched our episodes, and we look forward to bringing you many more insightful conversations. Thank you!
Links:
Ep. 2: How COVID-19 is transforming telehealth now and in the future
Ep. 35: Zeke Emanuel on the path to a vaccine (and why it's much harder than you think)
Ep. 69: CEO Warner Thomas on 20 years of digital innovation at Ochsner Health
Ep. 159: Ozempic, Wegovy, and our questions on weight management drugs
3 paths to the future of obesity care (and how to get there)
5 catalysts that will impact the future of weight management drugs
What the headlines get wrong about weight-management medications
How Cone Health added ATTR-CM screening to an existing care pathway: A TAVR example
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Generative AI is one of the most widely discussed topics in the industry today. There is continued excitement, mounting anxiety, and dozens of questions for health leaders to answer. While the healthcare industry has been working tirelessly to adapt to the almost unbelievable rate of change, many organizations struggle with how to ethically implement and scale Artificial Intelligence.
This week, host Rachel (Rae) Woods invites Duke University Health System's Chief Information Officer, Dr. Eric Poon, to discuss how Duke has approached ethical implementation of AI—and how their efforts started long before ChatGPT existed. Throughout the conversation, they discuss the early challenges Duke faced, offer tactical guidance for successful implementation, and explain why proper governance is critical to ethical AI adoption.
Links:
Duke Health | Connect with your health care at Duke Health
The best AI strategy isn't about AI
AI in healthcare: Insights from 10 C-suite executives
Ep. 180: Tom Lawry on why AI has a PR problem
Using simplified clinical criteria to screen more patients for ATTR-CM
Learn about Advisory Board Fellowship
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
The healthcare industry has been rocked by the pandemic and thrown headfirst into a new era of technological and therapeutic revolution. Yet, in the midst of all this change and uncertainty, healthcare leaders are expected not just to survive, but actually drive value for their organizations, patients, and communities. The problem is, “driving value” is not only complex, but it’s also ambiguous. Leaders who talk about value across the industry may not even be talking about the same thing. So, how should the industry think about driving value and what does it take to get this right?
In this episode, live from Advisory Board’s 2024 Value Summit, host Abby Burns invites Stacey Richter, healthcare entrepreneur, co-president of Aventria Health Group, and host of the Relentless Health Value podcast, to break down what “value” in healthcare actually means, where organizations go wrong, and how we can work to improve value across the industry.
Links:
Raising the Value Bar Virtual Summit
Our Value-Based Care playlist
EP358: How Health Insurance Plan Design Can Lead to Patients Sacrificing Needed Care, Their Mental Health, and (Sometimes) Buying Groceries, With Wayne Jenkins, MD | Relentless Health Value™
EP391: Lessons for Private Equity and Others Trying to Do Right by PCPs and Their Patients, With Scott Conard, MD | Relentless Health Value™
EP427: How Do Digital Health Vendors Deliver Patient Outcomes and Experiences? With Rik Renard | Relentless Health Value™
EP432: The Knifepoint Intersection of Margin and Mission and the Peril of Cutting Clinical “Waste,” With Kate Wolin, ScD | Relentless Health Value™
The challenges with migraine care — and what health systems can do about it
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
The rise of generative AI has impacted healthcare in many ways – one of which is that it’s pushing Big Tech toward becoming not just a relevant, but a central player in the industry. And when we’re talking Big Tech, we have to include Google. Google’s activity in healthcare has been turbulent since it entered the space nearly two decades ago, but it’s impossible to deny the significance of the contributions it’s made to the industry.
Now with the rapid growth of genAI, Google is refining its healthcare strategy to drive maximum impact in the areas it’s best positioned to – places like consumer, therapeutics, diagnostics, and more.
At the forefront of this work is Dr. Karen DeSalvo, Google’s Chief Health Officer. This week, guest host Eric Larsen, President Emeritus of Advisory Board and President of Towerbrook Advisors sits down with Dr. DeSalvo to unpack the seemingly boundless opportunities of generative AI to evolve healthcare and the unique—and scoped—role Google is playing in helping advance that evolution.
Links:
Lessons from the C-suite
AI in healthcare: Insights from 10 C-suite executives
Ep. 197: Lessons from the C-Suite: Demystifying generative AI with Dr. John Halamka, President of Mayo Clinic Platform
Ep. 185: AI adoption: why you can't afford to "wait and see"
Ep. 180: Tom Lawry on why AI has a PR problem
The chronic condition we should be talking about: Challenges and opportunities in migraine care
Learn about Advisory Board Fellowship
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
So far in our series on bespoke care and innovation, we’ve delved into the future of cancer care and the opportunities for equity in precision medicine. But we can’t conclude our series without talking about one of the most exciting developments in the field: cell and gene therapies. We’ve talked about these therapies on the pod before—but like everyone else, we’ve primarily focused on the payment side of the equation and looked at how purchasers and pharma can work together to ensure patient access. These conversations miss the voice of a key stakeholder: providers.
What is the role of the provider organizations in realizing the value of cell and gene therapies? To answer that question, in the final episode of our series leading up to Advisory Board’s Clinical Innovation Summit: Revolutions in Specialty Care, host Rachel (Rae) Woods invites Advisory Board pharmacy experts Gina Lohr and Chloe Bakst to unpack how providers are grappling with how to get these life-changing treatments to those that need them.
Links:
Ep. 210: How you approach precision medicine matters—for some patients more than others
Ep. 209: Predicting what oncology will look like in 2030
4 things leaders need to know about high-cost drugs
3 takeaways on why primary care is key to migraine management
Register for the Revolutions in Specialty Care Summit
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
It's no secret that healthcare is becoming more and more personalized – or “bespoke” – as increasingly sophisticated diagnostics and therapeutics continue to explode into the market. This vast pipeline is redefining the industry in several ways—but there is real risk associated if the stakeholders responsible for developing, delivering, and paying for these innovations aren’t baking health equity into their business models.
Last week, in the first episode of our run up to the Advisory Board Clinical Innovation Summit: Revolutions in Specialty Care, we discussed Advisory Board’s prediction for the future of oncology. This week, host Rachel (Rae) Woods invites Advisory Board experts Amanda Okaka and Fanta Cherif to break down the health equity conundrum presented by precision medicine: Will precision medicine reduce health disparities, or exacerbate them? The answer depends on the actions—big and small—of industry leaders.
Links:
Register for the Revolutions in Specialty Care Summit
How precision medicine can help us move from race-based to race-conscious medicine
Ep. 209: Predicting what oncology will look like in 2030
Ep. 204: Unveiling "Bespoke Care": Healthcare's tailored future
Bespoke care, part 1: What it is and how it’s transforming care delivery
Register for the Clinical Innovation Summit
A transcript of this episode as well as more information and resources can be found on radioadvisory.advisory.com.
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
United States
Thor Sound Booster
sogood voice the better peace world..♥️🎉🧿